Area of research
Surgery · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Coronary Interventions and Diagnostics, Cardiac Imaging and Diagnostics, Peripheral Artery Disease Management, and Cerebrovascular and Carotid Artery Diseases.
Orbital atherectomy versus balloon angioplasty before drug-eluting stent implantation in severely calcified lesions eligible for both treatment strategies (ECLIPSE): a multicentre, open-label, randomised trial
Intravascular Imaging vs Angiography Guidance for PCI of Severely Calcified Lesions
Paclitaxel-Coated Balloon for the Treatment of Multilayer In-Stent Restenosis
Ticagrelor monotherapy versus ticagrelor plus aspirin in patients with chronic coronary syndrome and high ischaemic risk: a post hoc analysis of the TWILIGHT trial
Impact of ticagrelor with or without aspirin on total and recurrent bleeding and ischaemic events after percutaneous coronary intervention: a sub-study of the TWILIGHT trial
Ticagrelor with or without aspirin following percutaneous coronary intervention in high-risk patients with concomitant peripheral artery disease: A subgroup analysis of the TWILIGHT randomized clinical trial
Optical Coherence Tomography–Guided versus Angiography-Guided PCI
Management strategies for heavily calcified coronary stenoses: an EAPCI clinical consensus statement in collaboration with the EURO4C-PCR group
Dyspnea-Related Ticagrelor Discontinuation After Percutaneous Coronary Intervention
Bleeding and Ischemic Risks of Ticagrelor Monotherapy After Coronary Interventions
Clinically Driven Revascularization in High-Risk Patients Treated With Ticagrelor Monotherapy After PCI: Insights from the Randomized TWILIGHT Trial
Antithrombotic strategy variability in atrial fibrillation and obstructive coronary disease revascularised with percutaneous coronary intervention: primary results from the AVIATOR 2 international registry
Safety and efficacy of ticagrelor monotherapy according to drug-eluting stent type: the TWILIGHT-STENT study
Ticagrelor monotherapy after PCI in patients with concomitant diabetes mellitus and chronic kidney disease: TWILIGHT DM-CKD
Ticagrelor Monotherapy After PCI in High-Risk Patients With Prior MI
Bleeding and Ischemic Outcomes With Ticagrelor Monotherapy According to Body Mass Index
Ticagrelor with and without aspirin in patients with a prior coronary artery bypass graft undergoing percutaneous coronary intervention: the TWILIGHT-CABG study
Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR
Ticagrelor monotherapy in patients with chronic kidney disease undergoing percutaneous coronary intervention: TWILIGHT-CKD
Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI
Impact of Age on the Safety and Efficacy of Ticagrelor Monotherapy in Patients Undergoing PCI
Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Artery Disease
Ticagrelor With or Without Aspirin After Complex PCI
Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS
Ticagrelor With or Without Aspirin in High-Risk Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention
Calcific Plaque Modification by Acoustic Shock Waves
Ticagrelor with or without Aspirin in High-Risk Patients after PCI
Optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation (ILUMIEN III: OPTIMIZE PCI): a randomised controlled trial